Group Therapies for Reducing HIV-Risk Behavior in Women Who Have Survived Childhood Sexual Abuse
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study will evaluate the effectiveness of trauma-focused group therapy for reducing HIV-risk behavior and revictimization among adult women survivors of childhood sexual abuse (CSA).
| Condition | Intervention | Phase |
|---|---|---|
|
Alcoholism Child Abuse, Sexual Sexual Abuse Sexual Behavior Sexually Transmitted Diseases, Viral |
Behavioral: Trauma-focused group therapy |
Phase 2 Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Factorial Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Group Interventions to Prevent HIV in High Risk Women |
- Rates of using of drugs or alcohol
- Sexual revictimization rates
- Rates of engaging in risky sex
- Trauma symptoms
| Estimated Enrollment: | 192 |
| Study Start Date: | September 1999 |
| Study Completion Date: | June 2002 |
The primary purpose of this study is to evaluate the effectiveness of trauma-focused group therapy for reducing HIV risk behavior and revictimization among adult women survivors of childhood sexual abuse (CSA). Research indicates that childhood sexual abuse is a major risk factor for becoming HIV-infected. Individuals with CSA may be less able to benefit from HIV/AIDS prevention intervention if they are continuing to be traumatized by their earlier CSA experiences that interfere with their learning safer patterns of interpersonal and personal functioning. This study will examine whether or not it is helpful to focus on survivors' memories of CSA in order to reduce HIV risk behavior, revictimization, and distress. It will also examine potential mediators of treatment effectiveness for CSA survivors. This randomized clinical intervention trial will compare trauma-focused group therapy against a present-focused group therapy comparison condition and a case-management only control condition. All three groups will be provided with case management. We will recruit a total of 192 adult women survivors of childhood sexual abuse through newspaper advertisements and through local community organizations (e.g., community health clinics, rape crisis centers). All 192 research participants will meet criteria for posttraumatic stress disorder (PTSD) for CSA as well as have engaged in HIV risk behavior and/or experienced sexual revictimization within the past 3 months. These research participants will be recruited for a randomized clinical intervention trial to evaluate the effectiveness of the trauma-focused and present-focused treatment conditions and to identify mediators of treatment effects. Women for the randomized clinical intervention trial will be recruited in eight cohorts of 24 subjects each for randomization to treatment condition (trauma-focused or present-focused or case management only). Intervention subjects will be assessed on behavioral and other psychosocial measures at baseline and at 3-, 6-, 9-, and 12-month follow-up assessments to evaluate the effectiveness of trauma-focused treatment against the present-focused treatment and the case management only control condition in reducing HIV risk behavior, sexual revictimization, and trauma symptoms, and improving interpersonal functioning. We will examine three mediators of treatment effectiveness, including: 1) trauma reactive and resilient beliefs about self and the world; 2) differentiation and integration of self; and 3) interpersonal relations.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
1. Female. 2. 18 years of age or older. 3. English-speaking. 4. Has at least two explicit memories of sexual abuse that involved genital contact.
5. At least two sexual abuse events occurred when the survivor was between 4 and15 years of age.
6. The perpetrator was at least 5 years older than the survivor. 7. The survivor knew the perpetrator prior to the sexual abuse. 8. The survivor has discussed or attempted to discuss details of the sexual abuse previously with another person (e.g., family member, friend, or therapist) at least 6 months prior to being interviewed for the study.
9. Meets DSM-IV criteria for current PTSD. 10. Provides informed consent.
And at least one of the following:
11. Has been sexually revictimized within the previous year. 12. Has engaged in risky sexual behavior within the previous year. 13. Meets DSM-IV criteria for substance abuse
Exclusion Criteria:
Criteria for exclusion includes any of the following:
- Diagnosed as meeting one of the following diagnostic categories: schizophrenia and other psychotic disorders; dementia and delirium and amnestic or other cognitive disorders.
- Reports ritual abuse.
- Is currently receiving psychotherapy (including individual or group psychotherapy).
- Individuals who are alcohol or drug dependent as defined by the DSM-IV.
- Individuals who are currently suicidal (i.e. within the last month)
Contacts and Locations| United States, California | |
| Dept. of Psychiatry, Stanford University | |
| Stanford, California, United States, 94305 | |
| Principal Investigator: | David Spiegel, M.D. | Stanford University |
| Study Director: | Catherine C. Classen, Ph.D. | Stanford University |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00220597 History of Changes |
| Other Study ID Numbers: | R01 MH60556, DAHBR AZ-Q |
| Study First Received: | September 15, 2005 |
| Last Updated: | February 29, 2008 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institute of Mental Health (NIMH):
|
group therapy sexual revictimization risky sex addiction |
Additional relevant MeSH terms:
|
Alcoholism Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Virus Diseases Alcohol-Related Disorders |
Substance-Related Disorders Mental Disorders Infection Genital Diseases, Male Genital Diseases, Female |
ClinicalTrials.gov processed this record on May 21, 2013